Household Healthcare Sector

Can B

Market Cap: US$2.8m

Develops, manufactures, and sells hemp biomass derived products containing cannabinoids.

Windtree Therapeutics

Market Cap: US$2.8m

A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.

Catheter Precision

Market Cap: US$2.8m

Designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States.

NLS Pharmaceutics

Market Cap: US$2.8m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders.

Bod Science

Market Cap: AU$4.3m

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States.

Qualigen Therapeutics

Market Cap: US$2.8m

A clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States.

ValiRx

Market Cap: UK£2.1m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

Marvel Biosciences

Market Cap: CA$3.8m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

Awakn Life Sciences

Market Cap: CA$4.0m

A biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe.

IQ-AI

Market Cap: UK£2.0m

Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, Switzerland, European Union, and the United States.

Optimus Healthcare Services

Market Cap: US$2.7m

Provides community-based oncology practices with the necessary infrastructure and support to enroll their patients on clinical trials in the United States.

Psyence Biomedical

Market Cap: US$2.7m

Engages in the development of botanical psilocybin-based psychedelic medicines.

Scinai Immunotherapeutics

Market Cap: US$2.7m

A development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel.

Spruce Biosciences

Market Cap: US$2.7m

A biopharmaceutical company, focuses on developing and commercializing novel therapies for neurological disorders.

Tivic Health Systems

Market Cap: US$2.7m

Operates as a health tech company, develops and commercializes bioelectronic medicine.

Herbal Dispatch

Market Cap: CA$3.7m

Owns and operates cannabis e-commerce platforms in Canada and the United States.

Patrys

Market Cap: AU$4.1m

Develops and commercializes antibody technologies for the treatment of cancer in Australia.

Alzamend Neuro

Market Cap: US$2.6m

A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.

One World Products

Market Cap: US$2.6m

One World Products, Inc. intends to produce raw cannabis and hemp plant ingredients for medical and industrial uses.

Talis Biomedical

Market Cap: US$2.6m

Operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States.

Ridder Titan Genesis

Market Cap: US$2.5m

A medical marijuana company, focuses on the development of whole plant extractions for the cancer and palliative treatments.

Freedom Care Group Holdings

Market Cap: AU$4.0m

Provides care and support services to individuals with disabilities in Australia.

Intelicare Holdings

Market Cap: AU$3.9m

Engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia.

Revelation Biosciences

Market Cap: US$2.5m

Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.

Endexx

Market Cap: US$2.5m

Engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market.

Megola

Market Cap: US$2.5m

Develops and sells various physical water treatment devices.

Stem Cell Authority

Market Cap: US$2.4m

A technology development company, focuses on the collection and cryogenic preservation of stem cells.

Xebra Brands

Market Cap: CA$3.4m

Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico.

THC Biomed Intl

Market Cap: CA$3.3m

Produces and sells medical and recreational cannabis in Canada.

Aptevo Therapeutics

Market Cap: US$2.4m

A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.

Escalon Medical

Market Cap: US$2.4m

Engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally.

Venus Concept

Market Cap: US$2.4m

A medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

ReShape Lifesciences

Market Cap: US$2.3m

Provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.

Helius Medical Technologies

Market Cap: US$2.3m

A neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma.

PHSC

Market Cap: UK£1.7m

Through its subsidiaries, provides health, safety, hygiene, and environmental consultancy services and security solutions to the public and private sectors in the United Kingdom.

SETO Holdings

Market Cap: US$2.3m

A development stage company, provides healthcare services.